We hardly ever stop to take a breath! Keep up-to-date with the Lung Health Foundation’s latest news.
LHF in the News
Media Release
July 3, 2024
The Lung Health Foundation (LHF) (lunghealth.ca), Canada’s leading non-profit lung health organization, today announced new appointments to its Board of Directors, reinforcing its commitment to improving lung health for all Canadians.
May 31, 2024
In alignment with World No Tobacco Day, the Lung Health Foundation has partnered with Ontario’s Public Health Units to introduce the Brief Conversations Toolkit, a robust bilingual online resource that aims to shrink the unprecedented youth vaping crisis in Canada by increasing brief contact intervention (BCI) knowledge and application among those who work with or care for the nation’s youth.
May 15, 2024
On the frontlines: Our mobile smoking & vaping quit app Quash is hitting 100+ Ontario high schools this spring.
Blog
June 8, 2026
To help our coast-to-coast community prepare, the Lung Health Foundation has created this simple preparation checklist. It will be of special interest to people who live near typical fire zones – but remember, the effects of wildfire smoke can often travel thousands of kilometers away.
May 30, 2026
Over 20 key health organizations and tobacco control experts from across the country convened in Ottawa this weekend for a national roundtable on the future of tobacco control in Canada. Concerned with high rates of youth vaping and the increasing use of nicotine pouches, the roundtable participants released a consensus statement calling for a new national target of reducing nicotine use to less than 5% by 2045. The existing target of less than 5% tobacco use by 2035 was reaffirmed.
May 20, 2026
New lung cancer and respiratory treatments are being developed faster than critically ill Canadian patients can access them, even when doctors believe they could help save lives; Canada’s largest charity dedicated to lung health presses Ottawa to act on Bill C-265 to establish a pre-approved special access list to help physicians obtain targeted therapies when no comparable treatment is available in Canada
